Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

20.30
Delayed Data
As of 3:59pm ET
 +0.05 / +0.25%
Today’s Change
16.40
Today|||52-Week Range
43.63
-52.55%
Year-to-Date

Today’s Trading

Previous close20.25
Today’s open20.20
Day’s range19.85 - 20.50
Volume434,733
Average volume (3 months)615,972
Market cap$933.8M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-81.73%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.19+3.72%
AMPHAmphastar Pharmaceut...+0.52+2.64%
PTLAPortola Pharmaceutic...+0.62+3.58%
CORTCorcept Therapeutics...+0.05+0.63%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.10
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts


Search for Jobs